Why is Hemo Organic falling/rising?

As of 01-Aug, Hemo Organic Ltd's stock price is currently at 8.52, reflecting a decline of 0.43, or 4.8%. The stock has underperformed its sector by 4.29% today and has been on a downward trend, experiencing consecutive losses over the last two days with a total drop of 4.91%. In terms of longer-term performance, the stock has seen a significant decline of 31.62% year-to-date and a staggering 78.27% over the past three years. Despite some positive quarterly results, including the highest PBDIT and PAT figures, the company faces serious challenges, including a negative book value and high debt levels, which contribute to its weak long-term fundamental strength. In the broader market context, Hemo Organic's recent performance contrasts sharply with the Sensex, which has only declined by 1.06% over the past week. The stock's negative returns over various periods highlight its struggles, particularly against the benchmark, which has shown resilience with a 3.15% increase year-to-date. The company's high debt-to-equity ratio and negative EBITDA further exacerbate its risk profile, making it a less attractive investment compared to the overall market. This combination of poor performance metrics and unfavorable financial conditions has led to a bearish sentiment surrounding Hemo Organic Ltd.